Study characteristics and quality assessment
Table 1 lists detailed information from the 5 included studies. The included studies were published between 2014 and 2019. The number of participants per study ranged from 22 to 90, with a total number of 228. Patients have received fingolimod were recorded in 114 of 228 (50%). All studies were randomized controlled trials.
Table 1 Clinical and demographic characteristics of 228 patients from 5 studies included in the systematic review